A cetaminophen is one of the most commonly consumed medications worldwide, either alone or in combination with other over-the-counter or prescription products, including opioids. 1 In the United States, 82,000 emergency room visits and 26,000 hospitalizations are attributed to acetaminophen overdose annually. 2, 3 Acetaminophen toxicity is also the leading cause of acute liver injury (ALI) and acute liver failure (ALF) in the United States, accounting for approximately 50% of all ALF cases. Given the clinical implications of this disease, and the growing opioid epidemic in the United States, it is essential to identify those at highest risk.
Sex differences in the epidemiology and natural history of many diseases are evident, with growing adoption of sex-based models of care for medical conditions outside the realm of hepatology. [4] [5] [6] Sex differences are also described in the presentation and clinical course of many liver diseases, 7 including a higher risk of ALF in women for many etiologies. [8] [9] [10] [11] Prior data on sex and ALF outcomes have largely focused on idiopathic drug injury (drug-induced liver injury [DILI] ), where women are noted to be at increased risk of progression to ALF. 12 The reasons for increased prevalence and severity of DILI in women are not clear, although may relate to greater use of hepatotoxic medications in women, 1, 13 and differential drug metabolism by sex.
14 Despite apparent sex differences in the prevalence and progression of other etiologies of ALF, less is known regarding the natural history of acetaminophen-induced ALF in men and women.
Using data from the prospective, multicenter Acute Liver Failure Study Group (ALFSG) cohort we aimed to evaluate sex differences in the presentation and clinical course of acetaminophen-induced ALI and ALF, and to secondarily compare overall and transplant-free survival by sex. Understanding the differential risk and clinical course of acetaminophen-induced ALI and ALF in men and women could help to reduce the burden of disease, while optimizing the management of those that progress to liver failure.
Patients and Methods

Study Population
We evaluated differences in presentation and clinical course between men and women with acetaminopheninduced ALI and ALF within the ALFSG. The ALFSG is a national registry of 32 academic medical centers in North America designed to examine clinical data and outcomes in adults with ALI and ALF. Detailed study protocols are previously described. 15 ALI was defined as acute hepatic illness <2 weeks with international normalized ratio (INR) 2.0, and alanine aminotransferase (ALT) >10 times the upper limit of normal and total serum bilirubin >3 mg/dL, without encephalopathy. ALF was defined by an INR of 1.5, disease duration of <26 weeks, the absence of prior chronic liver disease, with the presence of hepatic encephalopathy (HE). Patients with acetaminophen overdose between January 1, 2000, and September 27, 2016, were included in the current study. Acetaminophen was determined to be the etiology of ALI or ALF if there was a history of potentially toxic acetaminophen ingestion within a week of presentation, detection of any level of acetaminophen in the serum, or ALT >1000 IU/L with any history of acetaminophen ingestion irrespective of acetaminophen level. Per institutional review board guidelines, informed consent was obtained from patients or next of kin before enrollment. Patients with missing or unknown 21-day follow-up status, or liver transplant before study enrollment, were excluded.
Data Collection
Patient demographics (age, sex, race, and ethnicity), medical and psychiatric history, medication use, substance use (alcohol and illicit drugs), and acetaminophen ingestion details (suicidal intent, dose, timing, coingestions) were obtained at study entry from the patient or primary contact, because history was limited by HE in most patients. Data were often corroborated with patients after recovery. The case report forms also allowed investigators to describe other medical or psychiatric illnesses. Check boxes were available on data collection forms for most major medical/psychiatric conditions. Endocrine disorders reflected a single check box for any endocrine disorder (eg, diabetes). Psychiatric medications included antidepressants, antipsychotics, and nonbenzodiazepine anxiolytics. Heavy alcohol use was defined as >14 drinks per week within the past 6 months. Coingestions were considered those combining acetaminophen with other medications with sedating properties including opioids, benzodiazepines, and diphenhydramine. Intentionality was defined as a probable suicide attempt if a large quantity of acetaminophen was ingested at single time point or if suicidal intent was acknowledged by the patient or surrogate. Physical examination, laboratory values, and details of hospital course were obtained by study coordinators daily for 7 days, or until day of discharge if before 7 days. "Prestudy" data reflects peak laboratory values or clinical interventions performed at outside hospitals before ALFSG enrollment. These data were captured when available (in approximately 80% of patients). Seven-day follow-up reflects cumulative interventions through Day 7 postenrollment or through hospital discharge if patient discharged before Day 7. HE was graded 1 to 4 by the West Haven criteria; with grade 1 defined as mild changes in sensorium to grade 4 defined as coma. 16 The King's College criteria for acetaminophen-induced ALF were defined as having an arterial pH <7.30 or all 3 of the following: (1) grade 3 or 4 encephalopathy, (2) prothrombin time >100 seconds (INR >6.5), and (3) serum creatinine >3.4 mg/dL. 17 Standard 21-day outcome data captured by the ALFSG includes death, listing for liver transplant, and transplant-free and overall patient survival.
Statistical Analysis
Descriptive statistics were used to describe demographics, clinical characteristics, and outcomes. Continuous variables were reported as medians with interquartile ranges (IQR) due to nonnormal distributions. Sex differences in continuous and categorical variables were evaluated by Wilcoxon rank sum and chi square or Fisher exact test, respectively. All tests were 2-sided and P < .05 was considered significant. Multivariate models were performed using logistic regression with backward covariate selection. Variables were also excluded from the multivariable model if there was substantial missing data. We evaluated for interactions between sex and relevant clinical characteristics, with interaction P .10 considered statistically significant. Statistical analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC).
Results
Demographics and Comorbidities
Among the 1162 patients with acetaminophen toxicity enrolled between January 2000 and September 2016, a total of 250 (22%) had acetaminophen-induced ALI and 912 (78%) had acetaminophen-induced ALF. There were 17 patients in the cohort that presented with ALI and progressed to ALF who were analyzed only within the ALF group. Of patients in the ALFSG cohort with either acetaminophen-induced ALI or ALF, 864 (74%) were women, including 170 (68%) of the ALI patients and 694 (76%) of the ALF patients. Table 1 displays the baseline demographics, medical comorbidities, and ingestion characteristics for patients with acetaminophen-induced ALF stratified by sex. Women were older than men, with a median age of 37 (IQR, 29-47) versus 33 (IQR, 25-45) years (P < .01). The racial/ethnic distribution was similar by sex, with most (85%) of the cohort being white, and approximately 7% of all racial groups reporting Hispanic ethnicity. A greater proportion of women than men reported more than 12 years of formal education (42% vs 28%; P ¼ .01).
Regarding comorbid conditions, women with acetaminophen-induced ALF were more likely to have psychiatric disease (60% vs 48%; P < .01) and were more likely to be taking psychiatric medications (42% vs 25%; P < .001). Half of patients with psychiatric comorbidities had depression (52% in men, 48% in women), and an additional 15% had anxiety or a combination of anxiety and depression. Distribution of psychiatric illnesses did not differ between men and women (P ¼ .62). Regarding substance use, men were more likely to have a history of intravenous drug use (15% vs 7%; P < .01). Alcohol data were missing in 66% of the cohort, although a higher proportion of men than women reported recent heavy use (39% vs 19%; P < .01). Endocrine disorders were more common in women (60% vs 48%; P < .001), and a similar proportion (w 25%) of men and women were obese (body mass index >30).
Characteristics of Acetaminophen Use
Approximately half of patients with acetaminopheninduced ALF had unintentional acetaminophen overdose (53%), whereas 40% were suicide attempts (unknown intentionality in remaining 7%). Rates of suicide attempt were similar between men and women (44% and 38%, respectively; P ¼ .15). In those using acetaminophen for therapeutic purposes, acetaminophen use was more often self-initiated (77%) than recommended by physicians (23%); this was similar for men and women P ¼ .19). Only 15% of patients provided indications for acetaminophen use, of whom 42% reported use for chronic pain and 28% for acute pain, which was also similar by sex (P ¼ .5). There was no sex difference in reported total acetaminophen dose, even when adjusted for body weight (P ¼ .57). Interestingly, in women first acetaminophen level was performed a median of 48 hours (IQR, 24-72) after acetaminophen ingestion, compared with 24 hours (IQR, 24-72) in men (P ¼ .088), although median time to transfer to transplant center, and median time from symptom onset to either initial hospitalization or maximum HE, were similar (P > .2). At the time of study enrollment, 90% of all patients had been started on N-acetylcysteine (NAC).
Coingestions
A greater proportion of women had coingestions with either opioids, benzodiazepines, or diphenhydramine (70% vs 52%; P < .001). This was true for patients with and without suicide attempts. Interestingly, the prevalence of coingestions was lower in patients with documented suicide attempts, compared with those without (43% vs 65%; P < .001). Just over half of coingestions in women reflected opioid use, and all individual coingestion categories were more common in women than men (Figure 1 ). Approximately 25% of patients used a combination of sedating medications.
Clinical Characteristics by Sex
Prestudy peak, study entry, and peak clinical characteristics by sex are shown in Table 2 . At all time points, men had higher median ALT, bilirubin, creatinine, albumin, and Model for End-Stage Liver Disease scores, and lower sodium levels than women (P .02). However, weight-adjusted ALT was similar between men and women (55.2 vs 51.8; P ¼ .23). Women had lower phosphorus levels at study entry (P < .01) and follow-up (P ¼ .06), and lower study entry pH levels (P ¼ .04). INR, ammonia, acetaminophen, glucose, and lactate levels were not significantly different by sex (P .06). A higher proportion of men met Kings College Criteria at study entry, although this did not reach statistical significance (P ¼ .09).
Regarding complications of ALF, women were more likely to have high-grade HE (grade 3-4) at study entry (58% vs 42%) and during the 7-day follow-up period (68% vs 58%; P < .01) (Figure 2 ). Likewise, women were more likely to be intubated at study entry (60% vs 45%; P < .001) and during follow-up (67% vs 59%; P ¼ .03). Vasopressor (26% vs 19%; P ¼ .04) and mannitol use (13% vs 6%; P < .01) were also greater at study entry in women. Mannitol (22% vs 17%; P ¼ .09) and antibiotic use (14% vs 9%; P ¼ .06) were also more commonly used in women during follow-up. Despite these greater critical care needs in women, length of intensive care unit stay was similar by sex (P ¼ .29).
Risk of Severe Hepatic Encephalopathy
Given marked sex differences in prevalence of severe HE (grade 3-4), we evaluated whether female sex was an independent predictor of severe HE at study entry and followup. On univariate analysis, female sex was associated with increased risk of severe HE at both study entry (odds ratio [OR], 1.95; 95% confidence interval [CI], 1.43-2.67; P < .01) and follow-up (OR, 1.60; 95% CI, 1.17-2.20; P < .01). Covariates associated with severe HE are shown in Table 3 , which included coingestion use at study entry (OR, 1.64; 95% CI, 1.24-2.18; P < .01). On multivariate analysis the odds of severe HE remained significantly higher in women than men at both study entry (adjusted OR [AOR], 1.78; 95% CI, 1.28-2.51; P < .01) and follow-up (AOR, 1.66; 95% CI, 1.17-2.35; P < .01), independent of age, coingestions, study entry Model for End-Stage Liver Disease, and ALT levels. Importantly, we identified a significant interaction between sex and coingestions (study entry P ¼ .1; follow-up P < .01). On adjusted analysis, coingestions in women conferred a nearly 2-fold higher odds of severe HE at both study entry (AOR, 1.81; 95% CI, 1.26-2.59; P < .01) and follow-up (AOR, 1.86; 95% CI, 1.28-2.69; P < .01). In contrast, there was no significant difference in risk of severe HE in men by coingestion history at either study entry (AOR, 1.03; 95% CI, 0.57-1.84; P ¼ .93) or follow-up (AOR, 0.62; 95% CI, 0.34-1.13; P ¼ .12).
Overall and Transplant-Free Survival
Clinical outcomes at Day 21, stratified by sex, are shown in Figure 3 . Most patients with acetaminopheninduced ALF (75%) were alive at 21 days. Approximately 20% of patients were listed for liver transplant, 35% of which received a transplant. The median time to transplantation was 2.0 days. There were no significant sex differences in overall or transplant-free survival at 21 days (P .57).
Discussion
In this large US cohort, we identified novel sex differences in the presentation and clinical course of acetaminophen-induced ALI and ALF. Importantly, nearly three-quarters of patients with acetaminophen overdose were women. Moreover, women with acetaminophen-induced ALF were more likely to present with high-grade HE and to have critical care needs at both study entry and throughout hospitalization. Coingestions with sedating agents were not only more common in women, but also contributed to their greater risk for severe HE. Prior data on sex differences in ALF have largely focused on idiosyncratic (on-acetaminophen) DILI, suggesting that women may be more sensitive to hepatotoxicity. Women are more likely to present with DILI-induced ALF 12 and to require subsequent liver transplant. 18 Although recent studies have questioned whether women are systematically at greater risk of hepatotoxicity, 11, 19 it is clear that women are more likely to progress to DILI-induced ALF, and to have increased susceptibility to hepatotoxicity caused by specific medications. 11, [20] [21] [22] A striking finding in the current study was the higher prevalence of coingestions in women, most notably with combination opioid-acetaminophen products. These results have important public health implications in light of the current opioid epidemic in the United States, [23] [24] [25] particularly among younger Americans. 23, 26 According to National Health and Nutrition Examination Survey, 2 million Americans adults report using acetaminophen plus an opioid combination with acetaminophen. 13 In a 2015 study of patients with new acetaminophencontaining prescriptions, less than one-third were aware that their medication contained acetaminophen. Moreover, acetaminophen was identified on the primary container label by the full name "acetaminophen" on only 1 in 14 prescriptions. 27 In a US-based study of patients interviewed about their knowledge of over-thecounter acetaminophen-containing products, less than half were aware of potential risks of overdose by combining products. 28 More transparency in medication labeling and greater patient education regarding combination drug ingredients may help to reduce the morbidity and mortality associated with acetaminophen hepatotoxicity.
In the current study, women were not only more likely to ingest sedating agents but the risk of severe HE was nearly 2-fold higher among women with coingestions as compared with those without. This increased risk by coingestion history was not evident in men. Prior For arterial ammonia: on study entry, n ¼ 248; at study peak, n ¼ 278. For venous ammonia: on study entry, n ¼ 364; at study peak, n ¼ 418. Figure 2 . Clinical characteristics in acetaminopheninduced acute liver failure by sex at (A) study entry and (B) during cumulative 7-day follow up. data from the ALFSG have shown that acetaminophen in combination with opioids resulted in higher-grade encephalopathy than acetaminophen/diphenhydramine or acetaminophen alone. 29 However, despite greater coingestion use in the current study, female sex remained independently associated with severe HE at both study enrollment and follow-up. This suggests that factors beyond their greater coingestion use are at play, and could potentially reflect such factors as differences in acetaminophen metabolism by sex or differential patterns of acetaminophen use. 14, 30, 31 In humans, acetaminophen clearance has been shown to be 22% greater in men than women because of increased glucuronidation activity in men, 30 a key enzyme in acetaminophen metabolism. 31 These sex differences in glucuronidation activity are mitigated by oral contraceptive use, suggesting a potential hormonal contribution. 30 Studies from both the United States and Europe have also shown that women across age groups are more likely to use prescription and over-the-counter analgesics than men. 1, 13, 32, 33 Data from the US-based National Health and Nutrition Examination Survey from 1988 to 2004 found that women in the United States were more likely to use acetaminophen for pain, whereas men were more likely to use aspirin. In this study women were also more likely to use over-the-counter analgesics on a regular basis. 13 Women in the current study were more likely to have psychiatric disease, including anxiety and depression. Prior data from this cohort evaluating detailed psychiatric history found that rates of psychiatric illness in acetaminophen-induced ALF patients were higher than in the general population, in both intentional and unintentional overdoses. 34 In our cohort, suicidal intent was approximately 40% overall, and similar by sex. Acetaminophen dosage adjusted by weight and acetaminophen levels were also similar. Timing from ingestion to first acetaminophen measurement did vary by sex, with women having first levels drawn a median of 48 hours after ingestion, compared with 24 hours in men. Hepatotoxicity in women may have been recognized later than in men, leading to later and more severe illness on presentation or referral to tertiary care centers. Although there were no reported differences in time from symptom onset to initial hospitalization or in time to transfer to transplant center, data from outside hospitals before study enrollment are limited.
There are several notable limitations of the current study, including variable timing from outside hospital presentation to study enrollment. Details on outside hospital clinical parameters and interventions are not always recorded, such as timing from initial presentation to NAC administration, although approximately 90% of all patients were on NAC at the time of study enrollment. Although NAC use was not reported in 10% of suspected acetaminophen-induced ALF cases, this is likely caused by underreporting of NAC in certain centers, particularly before 2010, which has been identified in prior ALFSG analyses (data not shown). Underlying HE may also affect patient recall, including amount, timing, and coingestions details, although this information was extracted from medication records and/or patient families, then later verified with patients in most cases. Acetaminophen levels were missing on approximately one-third of patients, and alcohol history was missing in 66% of the cohort, the latter of which is a known P-450 inducer that increases production of the toxic acetaminophen metabolite N-acetyl-p-benzoquinone imine. 35 Despite these limitations, the ALFSG is the largest cohort of patients with acetaminophen-induced ALI and ALF to date, providing daily serologic and clinical measures, which allowed us to capture novel differences in the clinical course of acetaminophen-induced ALF between men and women. These findings can help to inform risk in women with combination acetaminophen and sedative use, and support the need for more restrictive use of opiates, particularly when used in combination with acetaminophen.
In summary, women comprise near three-quarters of patients presenting with acetaminophen-induced ALI and ALF in the United States. Women with acetaminopheninduced ALF have greater critical care needs than men, including more severe encephalopathy. These findings may help to guide inpatient management of women with acetaminophen hepatotoxicity, including consideration for earlier transfer to intensive care units, and aggressive monitoring of neurologic status. Importantly, coingestions are more common in women with acetaminopheninduced ALF, which differentially increases their risk of high-grade encephalopathy. In light of the current opioid epidemic, there is great need for awareness of the risk of combination acetaminophen-opioid agents in the outpatient setting, which differentially affects the morbidity of women with acetaminophen-induced ALF.
